SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001730463-20-000008
Filing Date
2020-08-06
Accepted
2020-08-06 16:06:11
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 6-K autl-20200630.htm   iXBRL 6-K 1277225
2 EX-99.1 autolus-20200630x6k.htm EX-99.1 30857
3 EX-99.2 exhibit992-operatingre.htm EX-99.2 257892
  Complete submission text file 0001730463-20-000008.txt   5757578

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT autl-20200630.xsd EX-101.SCH 39341
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT autl-20200630_cal.xml EX-101.CAL 61014
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT autl-20200630_def.xml EX-101.DEF 204911
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT autl-20200630_lab.xml EX-101.LAB 446654
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT autl-20200630_pre.xml EX-101.PRE 330409
9 EXTRACTED XBRL INSTANCE DOCUMENT autl-20200630_htm.xml XML 873405
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38547 | Film No.: 201081570
SIC: 2836 Biological Products, (No Diagnostic Substances)